Second-site NMR screening and linker design

被引:48
作者
Jahnke, W [1 ]
Flörsheimer, A
Blommers, MJJ
Paris, CG
Heim, J
Nalin, CM
Perez, LB
机构
[1] Novartis Pharma AG, Cent Technol, CH-4002 Basel, Switzerland
[2] Novartis Pharma AG, Oncol Res, CH-4002 Basel, Switzerland
[3] Novartis Pharma AG, Cent Technol, Summit, NJ 07901 USA
[4] Novartis Pharma AG, Oncol Res, Summit, NJ 07901 USA
关键词
D O I
10.2174/1568026033392778
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
One of the prime merits of NMR as a tool for lead finding in drug discovery research is its sensitivity and robustness to detect weak protein-ligand interactions. This sensitivity allows to build up ligands for a given target in a modular way, by a fragment-based approach. In this approach, two ligands are seperately identified which bind to the target protein generally weakly but at adjacent binding sites. In a next step, they are chemically linked to produce a high-affinity ligand. This review discusses methods to detect "second-site" ligands that bind to a protein in the presence of a "first-site" ligand, and methods to elucidate structural details on the spatial orientation of both ligands, so that chemical linkage is based on a large piece of experimental information. Published examples from second-site screening and linker design are summarized, and are complemented by previously unpublished in-house examples.
引用
收藏
页码:69 / 80
页数:12
相关论文
共 50 条
[41]   Motility defects in Campylobacter jejuni defined gene deletion mutants caused by second-site mutations [J].
de Vries, Stefan P. W. ;
Gupta, Srishti ;
Baig, Abiyad ;
L'Heureux, Joanna ;
Pont, Elsa ;
Wolanska, Dominika P. ;
Maskell, Duncan J. ;
Grant, Andrew J. .
MICROBIOLOGY-SGM, 2015, 161 (12) :2316-2327
[42]   Second-site suppression of a nonfunctional mutation within the Leishmania donovani inosine-guanosine transporter [J].
Arastu-Kapur, S ;
Arendt, CS ;
Purnat, T ;
Carter, NS ;
Ullman, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (03) :2213-2219
[43]   Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses [J].
O'Reilly, L ;
Roth, MJ .
JOURNAL OF VIROLOGY, 2000, 74 (02) :899-913
[44]   Second-site reversion of a dysfunctional mutation in a conserved region of the tobacco mosaic tobamovirus movement protein [J].
Deom, CM ;
He, XZ .
VIROLOGY, 1997, 232 (01) :13-18
[45]   Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome [J].
Boztug, K. ;
Germeshausen, M. ;
Diez, I. Avedillo ;
Gulacsy, V. ;
Diestelhorst, J. ;
Ballmaier, M. ;
Welte, K. ;
Marodi, L. ;
Chernyshova, L. I. ;
Klein, C. .
CLINICAL GENETICS, 2008, 74 (01) :68-74
[46]   Misfolding of chloramphenicol acetyltransferase due to carboxy-terminal truncation can be corrected by second-site mutations [J].
Van der Schueren, J ;
Robben, J ;
Volckaert, G .
PROTEIN ENGINEERING, 1998, 11 (12) :1211-1217
[47]   TWO FAMILIES OF NOVEL CFTR SECOND-SITE CORRECTORS WITH POTENTIAL FOR IMPROVING ON CURRENT TRIPLE MODULATOR THERAPY [J].
Li, F. ;
Zawistoski, M. ;
Bailey, V ;
Kwok, I ;
Oliver, R. ;
Krouse, M. E. ;
Morningstar, M. ;
Fitzpatrick, R. J. ;
Kolodziej, A. .
PEDIATRIC PULMONOLOGY, 2019, 54 :S350-S350
[48]   Screen to disrupt sct1, a second-site suppressor of Chlamydomonas reinhardtii, CRD1. [J].
Soto, F ;
Moseley, J ;
Merchant, S .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 :U196-U197
[49]   Restoration of domain folding and interdomain assembly by second-site suppressors of the ΔF508 mutation in CFTR [J].
He, Lihua ;
Aleksandrov, Luba A. ;
Cui, Liying ;
Jensen, Timothy J. ;
Nesbitt, Kenneth L. ;
Riordan, John R. .
FASEB JOURNAL, 2010, 24 (08) :3103-3112
[50]   Screening of an intragenic second-site suppressor of purine-cytosine permease from Saccharomyces cerevisiae -: Possible role of Ser272 in the base translocation process [J].
Ferreira, T ;
Chevallier, J ;
Paumard, P ;
Napias, C ;
Brèthes, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 260 (01) :22-30